A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
Recent technological advances have opened new possibilities for neuroscience research, allowing researchers to map the brain's structure and synaptic connectivity (i.e., the junctions via which ...
In experiments, researchers showed that the disease-spreading insects couldn’t resist the sweet smell of a fungus that infected and killed them.
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...
Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis ...
In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...
Liz Wood, who lives in Beacon, is the founder of The MYT1L Project ( myraregene.org ), a foundation that supports families whose children are affected by a rare genetic disorder.
From a quick online survey to a 77-gene DNA test, the initiative empowers patients across Missouri and beyond to take control ...
According to Nova One Advisor, the global genomics data analysis market size is calculated at USD 7.91 billion in 2025 and is ...
Natural spiderwebs are good at capturing DNA from the environment, but artificial webs are cheap and provide better control – ...
Medicare Part B data show that of the 20 CPT codes seeing the largest increase in payments from 2022 to 2024, all are for molecular- or sequencing-based tests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback